technetium Tc 99m trofolastat
Phase 3- Indications
- Prostate cancer
Company intelligence / Profile preview
Molecular Insight Pharmaceuticals, Inc.
Cambridge, Massachusetts, USAlinkedin.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Molecular Insight Pharmaceuticals developed a pipeline of small molecule-based targeted radiotherapeutics and diagnostics for oncology and cardiology. Its lead asset Azedra™ was in Phase 2 for rare adrenal tumors. The company also advanced PSMA-targeted imaging agents for prostate cancer into preclinical/early clinical development. Several programs were discontinued or outlicensed after acquisition by Progenics Pharmaceuticals in January 2013.
- Therapeutic areas
- OncologyEndocrinologyCardiovascular
- Modalities
- Small moleculesdiagnostic radiopharmaceuticalsradionuclide drug conjugates (RDCs)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Molecular Insight Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Molecular Insight Pharmaceuticals, Inc..